Emergency Approvals for COVID-19: Evolving Impact on Obligations to Patients in Clinical Care and Research

Abstract [from journal]

There currently is debate regarding whether U.S. institutions and clinicians may or should restrict patient access to COVID-19 drugs and vaccines that have been granted emergency use authorization by the U.S. Food and Drug Administration. The authors provide their views on the legal, ethical, and clinical ramifications of such restriction.